• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可注射避孕:皮下自我给药的新证据。

Injectable contraception: emerging evidence on subcutaneous self-administration.

机构信息

Division of Family Planning Services and Research, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, USA.

出版信息

Curr Opin Obstet Gynecol. 2019 Dec;31(6):464-470. doi: 10.1097/GCO.0000000000000574.

DOI:10.1097/GCO.0000000000000574
PMID:31567445
Abstract

PURPOSE OF REVIEW

Injectable contraception is a widely available and popular family planning method globally. It has evolved to allow for subcutaneous self-injection (DMPA-SC, Depo medroxyprogesterone acetate-subcutaneous). In this review, we will focus on research evaluating DMPA-SC, with specific regard to continuation rates, safety, and satisfaction among users.

RECENT FINDINGS

Emerging evidence from the United States, Malawi, Uganda, and Senegal has established safety and higher continuation rates among self-inject users, compared with provider-inject users. Continuation is 10-28% higher among DMPA-SC self-inject users. Self-inject users across studies were highly satisfied and reported DMPA-SC was easy to use. Studies indicate continuation is likely to be attributable to self-administration and user autonomy, rather than inherent properties of the DMPA-SC injection.

SUMMARY

DMPA-SC should be made available in high-resource and low-resource settings. Future efforts should be focused on implementation and evaluating how to best add DMPA-SC to the method mix. Cost-benefit analyses will need to evaluate the up-front costs of DMPA-SC for clients, facilities, and health systems compared with the higher continuation rates and saved opportunity-costs over time. Task-shifting strategies and development of mobile phone technologies to assist users in adherence should be considered in future service scale-up.

摘要

目的综述:全球范围内,可注射避孕法是一种广泛应用且广受欢迎的计划生育方法。该方法已经过改良,可以进行皮下自我注射(DMPA-SC,醋酸甲羟孕酮-皮下注射)。本综述将重点关注评估 DMPA-SC 的研究,具体涉及续用率、安全性和使用者满意度。

最新发现:来自美国、马拉维、乌干达和塞内加尔的新证据表明,与由医护人员注射相比,自我注射者使用 DMPA-SC 的安全性更高,续用率也更高。DMPA-SC 自我注射者的续用率高出 10-28%。多项研究表明,自我注射者对 DMPA-SC 的满意度非常高,且表示其易于使用。研究表明,续用率可能归因于自我管理和用户自主权,而不是 DMPA-SC 注射本身的固有特性。

总结:应在高资源和低资源环境中提供 DMPA-SC。未来的工作重点应放在实施上,并评估如何最好地将 DMPA-SC 添加到方法组合中。成本效益分析需要评估 DMPA-SC 对客户、设施和卫生系统的前期成本,以及随着时间的推移,续用率提高和机会成本降低所带来的效益。未来在扩大服务规模时,应考虑将任务转移策略和开发手机技术以帮助用户坚持使用相结合。

相似文献

1
Injectable contraception: emerging evidence on subcutaneous self-administration.可注射避孕:皮下自我给药的新证据。
Curr Opin Obstet Gynecol. 2019 Dec;31(6):464-470. doi: 10.1097/GCO.0000000000000574.
2
Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.自我注射与医护人员注射皮下储库型醋酸甲羟孕酮对马拉维续用率的影响:一项随机对照试验。
Lancet Glob Health. 2018 May;6(5):e568-e578. doi: 10.1016/S2214-109X(18)30061-5. Epub 2018 Mar 8.
3
Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi. Malawi 中皮下注射储库型醋酸甲羟孕酮(DMPA-SC)的使用者和提供者体验。
Contraception. 2018 Nov;98(5):405-410. doi: 10.1016/j.contraception.2018.02.011. Epub 2018 Apr 26.
4
Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.通过卫生工作者和自我注射管理注射避孕措施的成本:来自布基纳法索、乌干达和塞内加尔的证据。
Contraception. 2018 Nov;98(5):389-395. doi: 10.1016/j.contraception.2018.05.018. Epub 2018 May 30.
5
Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.当由医疗机构和社区卫生工作者提供皮下或肌内注射避孕措施时的持续使用情况:布基纳法索和乌干达的前瞻性队列研究结果。
Contraception. 2018 Nov;98(5):423-429. doi: 10.1016/j.contraception.2018.08.007. Epub 2018 Aug 17.
6
Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda.与机构卫生工作者提供的避孕注射相比,避孕自我注射是否具有成本效益?来自乌干达的证据。
Contraception. 2018 Nov;98(5):396-404. doi: 10.1016/j.contraception.2018.07.137. Epub 2018 Aug 9.
7
Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.塞内加尔自行注射与提供者管理避孕方法的延续:一项非随机、前瞻性队列研究。
Contraception. 2019 Feb;99(2):137-141. doi: 10.1016/j.contraception.2018.11.001. Epub 2018 Nov 12.
8
Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial.在一项随机试验中,皮下注射醋酸甲羟孕酮(DMPA-SC)的妇女的满意度、使用情况、储存和处理。
Contraception. 2018 Nov;98(5):418-422. doi: 10.1016/j.contraception.2018.04.018. Epub 2018 Jun 8.
9
Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi.影响皮下注射醋酸甲羟孕酮(DMPA-SC)持续使用的因素:马拉维为期 1 年的随机试验的二次分析。
Glob Health Sci Pract. 2019 Mar 29;7(1):54-65. doi: 10.9745/GHSP-D-18-00433. Print 2019 Mar 22.
10
Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.皮下注射醋酸甲羟孕酮避孕的家庭自我管理初步研究。
Contraception. 2012 May;85(5):458-64. doi: 10.1016/j.contraception.2011.10.002. Epub 2011 Nov 12.

引用本文的文献

1
Knowledge, confidence and social support: Kenyan women's priority needs for contraceptive self-injection learning through a social cognitive theory lens.知识、信心与社会支持:从社会认知理论视角看肯尼亚女性进行避孕自我注射学习的优先需求
BMC Womens Health. 2025 Jun 30;25(Suppl 1):289. doi: 10.1186/s12905-025-03801-4.
2
Examining the relationship between reproductive empowerment and contraceptive self-injection: Tackling the endogeneity problem.审视生殖自主权与避孕自我注射之间的关系:解决内生性问题。
PLoS One. 2025 Feb 24;20(2):e0319330. doi: 10.1371/journal.pone.0319330. eCollection 2025.
3
Patient experiences switching from in-clinic to self-administration of injectable contraception in two Western US states.
美国西部两个州的患者从诊所注射避孕转变为自行注射避孕的经历。
Perspect Sex Reprod Health. 2024 Dec;56(4):347-357. doi: 10.1111/psrh.12278. Epub 2024 Jul 4.
4
Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.在 COVID-19 大流行期间,在不同的实践环境中提供 DMPA-SC 供自我管理:来自美国各地提供者的数据。
Contraception. 2024 Mar;131:110360. doi: 10.1016/j.contraception.2023.110360. Epub 2023 Dec 27.
5
Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis.自我管理的皮下醋酸甲羟孕酮用于改善避孕效果:系统评价和荟萃分析。
BMC Womens Health. 2021 Oct 9;21(1):359. doi: 10.1186/s12905-021-01495-y.
6
COVID-19 and family planning service delivery: Findings from a survey of U.S. physicians.2019冠状病毒病与计划生育服务提供:美国医生调查结果
Prev Med. 2021 Sep;150:106664. doi: 10.1016/j.ypmed.2021.106664. Epub 2021 Jun 1.
7
Understanding the extent of contraceptive non-use among women at risk of unintended pregnancy, National Survey of Family Growth 2011-2017.《2011 - 2017年全国家庭成长调查》:了解有意外怀孕风险的女性中未使用避孕措施的情况。
Contracept X. 2020 Jul 11;2:100033. doi: 10.1016/j.conx.2020.100033. eCollection 2020.